4//SEC Filing
ARGOS THERAPEUTICS INC 4
Accession 0000899243-16-024115
CIK 0001105533operating
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 5:06 PM ET
Size
8.1 KB
Accession
0000899243-16-024115
Insider Transaction Report
Form 4
Birner Hubert
Director10% Owner
Transactions
- Purchase
Common Stock Warrants (right to buy)
2016-06-29+206,659→ 206,659 total(indirect: See footnote)Exercise: $5.35From: 2016-06-29Exp: 2021-06-29→ Common Stock (206,659 underlying) - Purchase
Common Stock
2016-06-29+275,545→ 1,930,333 total(indirect: See footnote)
Footnotes (2)
- [F1]The reported securities are included within Units purchased by the Reporting Person for $5.44375 per Unit. Each Unit consists of one share of common stock and one warrant to purchase 0.75 shares of common stock.
- [F2]The reported securities are directly held by TVM V Life Science Ventures GmbH & Co. KG ("TVM V"), the managing limited partner of which is TVM V Life Science Ventures Management GmbH & Co. KG ("TVM V Management"), for which the Reporting Person, Stefan Fischer ("Fischer"), Alexandra Goll ("Goll") and Axel Polack ("Polack"), each a member of the investment committee of TVM V Management, share voting and investment authority over the securities held by TVM V. Each of TVM V Management, the Reporting Person, Fischer, Goll and Polack disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, if any.
Documents
Issuer
ARGOS THERAPEUTICS INC
CIK 0001105533
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001105533
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 5:06 PM ET
- Size
- 8.1 KB